Cercar
01/08/2024
Spanish Consensus on Remission in Asthma (REMAS)
Alvarez-Gutiérrez, FJ, Casas-Maldonado, F, Soto-Campos, G, Blanco-Aparicio, M, Delgado, J, Galo, AP, Quirce, S, Plaza, V. Spanish Consensus on Remission in Asthma (REMAS). ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(8)DOI:10.1016/j.arbres.2024.04.002. PMID:38697903. IF:9.200(Q1/1D).
01/06/2024
Diagnostic Value of Krebs von den Lungen (KL-6) for Interstitial Lung Disease: A European Prospective Cohort
Millan-Billi, P, Castellví, I, Martinez-Martinez, L, Mariscal, A, Barril, S, D'Alessandro, M, Franquet, T, Castillo, D. Diagnostic Value of Krebs von den Lungen (KL-6) for Interstitial Lung Disease: A European Prospective Cohort. ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(6)DOI:10.1016/j.arbres.2024.03.028. PMID:38644152. IF:9.200(Q1/1D).
01/06/2024
The impact of smoking on bronchiectasis and its comorbidities
de la Rosa-Carrillo, D, de Granda-Orive, JI, Cáceres, LD, Pereyra, FG, Moreno, BR, Martínez-Garcia, MA, Suárez-Cuartin, G. The impact of smoking on bronchiectasis and its comorbidities. Expert Review of Respiratory Medicine. 2024; 18(5)DOI:10.1080/17476348.2024.2369716. PMID:38888096. IF:2.700(Q2/5D).
01/06/2024
BASELINE CHARACTERISTICS OF PATIENTS WITH ASTHMA AND PRIOR ORAL SYSTEMIC CORTICOSTEROID USE INITIATING DUPILUMAB IN A REAL-WORLD REGISTRY (RAPID)
Lugogo, NL, Heffler, E, Plaza,, Hilberg, O, Xia, C, Nash, S, Pandit-Abid, N, Jacob-Nara, JA, Sacks, H, Rowe, PJ, Deniz, Y, Hardin, M, Reed, C, Soler, X. BASELINE CHARACTERISTICS OF PATIENTS WITH ASTHMA AND PRIOR ORAL SYSTEMIC CORTICOSTEROID USE INITIATING DUPILUMAB IN A REAL-WORLD REGISTRY (RAPID). VALUE IN HEALTH. 2024; 27(6)DOI:. PMID:. IF:6.000(Q1/1D).
01/05/2024
Unraveling the Enigma: Spain Takes a Pioneering Step With REPAIR in the World of Inhaled Antibiotics
de la Rosa-Carrillo, D, Miravitlles, M, Pomares, X, Martínez-García, MA. Unraveling the Enigma: Spain Takes a Pioneering Step With REPAIR in the World of Inhaled Antibiotics. ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(5)DOI:10.1016/j.arbres.2024.01.007. PMID:38310073. IF:9.200(Q1/1D).
01/05/2024
Extrafine Formulation Single-inhaler Triple Therapy Improves Lung Function After Six Months of Treatment in Patients With Asthma: Trimaximize Study
Gessner, C, Bogoevska, V, Nachtigall, D, Russell, R, Ulrik, CS, Pohl, W, Plaza, V, Bourdin, A, Akyildiz, B, Trinkmann, F. Extrafine Formulation Single-inhaler Triple Therapy Improves Lung Function After Six Months of Treatment in Patients With Asthma: Trimaximize Study. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2024; 209DOI:. PMID:. IF:19.400(Q1/1D).